Reno, Nevada – July 10, 2025
The patented low-odor cannabis product of High Sierra Technologies, Inc. known as the brand named Hush Puppy™ is currently available in 10 dispensaries across California, with additional retailers coming online as demand continues to grow. This early traction validates both the consumer appeal and commercial viability of our proprietary technology, which offers a discreet cannabis experience without compromising quality. Building on this momentum, our next strategic objective is to expand distribution into additional legal markets across the United States, beginning with targeted partnerships in high-growth states where discretion and innovation are key differentiators.
About High Sierra Technologies, Inc.
High Sierra Technologies, Inc. is a company specializing in the development and licensing of patentable technology for use in the creation of substantially odorless and tasteless marijuana products. The company’s website is www.high-sierra.com.
Forward-Looking Statements
This Press Release contains forward-looking statements. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “intend,” “expect,” “anticipate,” “could,” “may,” “should,” “will,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in High Sierra Technologies, Inc.’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown uncertainties and other factors which are, in some cases, beyond High Sierra Technologies, Inc.’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects High Sierra Technologies, Inc.’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions; the impact of general economic, health, industrial or political conditions in the United States or internationally; and other risks and uncertainties identified in High Sierra Technologies, Inc.’s disclosure documents filed with the Securities and Exchange Commission. High Sierra Technologies, Inc. assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.
No product referred to in this press release has been approved, in any manner whatsoever, by the U.S. Food & Drug Administration. No product referred to in this press release is intended to diagnose, treat, cure or prevent any disease.
HSTI trades under OTC symbol “HSTI”.
Our website may be viewed at www.high-sierra.com.
Investor Relations Contact
info@high-sierra.com
Telephone No.: 775.410.4100
Comments (0)